Sudarshan Pharma

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE00TV01023
  • NSEID:
  • BSEID: 543828
INR
37.00
1.85 (5.26%)
BSENSE

Oct 09

BSE+NSE Vol: 300000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
24.07
24.07
24.07
24.07
9.75
9.55
Share Warrants & Outstandings
Total Reserve
127.21
103.86
87.64
76.91
20.03
12.96
Shareholder's Funds
155.10
131.74
111.71
100.97
29.78
22.51
Minority Interest
1.22
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
28.37
10.43
10.49
12.79
4.94
5.32
Secured Loans
27.58
9.90
9.06
11.78
4.08
2.82
Unsecured Loans
0.79
0.53
1.43
1.01
0.86
2.50
Deferred Tax Assets / Liabilities
0.15
0.08
0.02
0.18
0.14
0.14
Other Long Term Liabilities
0.59
3.19
0.09
0.06
0.04
0.03
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.20
0.15
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
29.31
13.85
10.59
13.03
5.12
5.48
Current Liabilities
Trade Payables
187.72
91.98
56.72
91.89
73.75
44.22
Other Current Liabilities
13.27
8.32
9.76
5.27
3.22
5.62
Short Term Borrowings
255.11
160.36
94.35
21.32
25.65
21.38
Short Term Provisions
0.02
0.01
0.00
0.00
0.00
0.00
Total Current Liabilities
456.12
260.67
160.82
118.48
102.62
71.22
Total Liabilities
641.75
406.27
283.13
232.48
137.52
99.26
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
97.92
37.98
29.33
22.45
8.49
7.64
Less: Accumulated Depreciation
5.32
2.39
3.83
2.56
2.03
1.42
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
92.60
35.58
25.50
19.89
6.47
6.21
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
3.44
22.54
1.88
0.01
0.54
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
11.52
11.93
12.34
12.34
0.00
0.00
Long Term Loans & Advances
16.58
3.88
1.83
1.62
0.94
5.40
Other Non Current Assets
32.57
9.24
0.00
0.00
0.00
0.00
Total Non-Current Assets
151.48
78.82
41.55
33.86
7.94
11.62
Current Assets Loans & Advances
Current Investments
0.00
1.67
1.50
0.00
0.00
0.00
Inventories
218.74
140.48
85.74
74.57
46.87
23.96
Sundry Debtors
233.34
152.60
122.55
81.51
73.48
60.39
Cash and Bank
1.13
0.55
0.14
11.72
0.24
1.25
Other Current Assets
4.17
2.97
31.62
19.94
8.97
2.01
Short Term Loans and Advances
32.88
29.17
0.02
10.88
0.03
0.02
Total Current Assets
490.26
327.45
241.57
198.62
129.58
87.64
Net Current Assets (Including Current Investments)
34.15
66.78
80.75
80.14
26.96
16.42
Total Current Assets Excluding Current Investments
490.26
325.78
240.07
198.62
129.58
87.64
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
641.75
406.27
283.13
232.48
137.52
99.26
Contingent Liabilities
59.21
28.58
0.40
0.20
0.19
0.02
Total Debt
283.47
170.78
104.84
34.10
30.59
28.23
Book Value per share (adjusted)
0
5.32
4.642
4.196
2.036
1.572
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 65.99% vs 62.90% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is -81.50% vs 3,444.44% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 65.24% vs 112.27% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is -3.44% vs -3.32% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 49.72% vs 35.55% in Mar 2025

Compare Balance Sheet Results of Sudarshan Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
24.07
12.36
11.71
94.74%
Share Warrants & Outstandings
Total Reserve
127.21
108.01
19.20
17.78%
Shareholder's Funds
155.10
120.38
34.72
28.84%
Minority Interest
1.22
0.00
1.22
0.00%
Long-Term Borrowings
28.37
0.00
28.37
0.00%
Secured Loans
27.58
0.00
27.58
0.00%
Unsecured Loans
0.79
0.00
0.79
0.00%
Deferred Tax Assets / Liabilities
0.15
4.61
-4.46
-96.75%
Other Long Term Liabilities
0.59
0.00
0.59
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.20
0.19
0.01
5.26%
Total Non-Current Liabilities
29.31
4.80
24.51
510.62%
Current Liabilities
Trade Payables
187.72
18.17
169.55
933.13%
Other Current Liabilities
13.27
5.22
8.05
154.21%
Short Term Borrowings
255.11
0.00
255.11
0.00%
Short Term Provisions
0.02
5.60
-5.58
-99.64%
Total Current Liabilities
456.12
29.00
427.12
1,472.83%
Total Liabilities
641.75
154.18
487.57
316.23%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
97.92
115.27
-17.35
-15.05%
Less: Accumulated Depreciation
5.32
38.71
-33.39
-86.26%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
92.60
76.56
16.04
20.95%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
3.44
3.16
0.28
8.86%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
11.52
0.43
11.09
2,579.07%
Long Term Loans & Advances
16.58
1.98
14.60
737.37%
Other Non Current Assets
32.57
0.02
32.55
162,750.00%
Total Non-Current Assets
151.48
82.15
69.33
84.39%
Current Assets Loans & Advances
Current Investments
0.00
36.21
-36.21
-100.00%
Inventories
218.74
12.12
206.62
1,704.79%
Sundry Debtors
233.34
19.56
213.78
1,092.94%
Cash and Bank
1.13
2.11
-0.98
-46.45%
Other Current Assets
4.17
1.02
3.15
308.82%
Short Term Loans and Advances
32.88
1.01
31.87
3,155.45%
Total Current Assets
490.26
72.03
418.23
580.63%
Net Current Assets (Including Current Investments)
34.15
43.03
-8.88
-20.64%
Total Current Assets Excluding Current Investments
490.26
35.82
454.44
1,268.68%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
641.75
154.18
487.57
316.23%
Contingent Liabilities
59.21
0.93
58.28
6,266.67%
Total Debt
283.47
0.00
283.47
0.00%
Book Value per share (adjusted)
0.00
97.37
-97.37
-100.00%
Annual - Borrowings
Borrowings 283.47 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 65.99% vs 62.90% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.59 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -81.50% vs 3,444.44% in Mar 2025

Annual - Fixed Assets
Fixed Assets 96.04 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 65.24% vs 112.27% in Mar 2025

Annual - Investments
Investments 11.52 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -3.44% vs -3.32% in Mar 2025

Annual - Current Assets
Current Assets 490.26 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 49.72% vs 35.55% in Mar 2025